In this study, the relationship between the inhibitory effects of extracts from rye-buckwheat ginger cakes supplemented with low and high rutin dosage baked without or with dough fermentation step on the formation of fluorescent advanced glycation end-products (AGEs), and phenolic compounds, rutin, D-chiro-inositol and antioxidant capacity were addressed. The cakes were based on rye flour substituted by light buckwheat flour or flour from roasted buckwheat groats at 30% level, and were produced with or without dough fermentation step. The inhibitory effect against AGEs formation was studied in bovine serum albumin (BSA)-glucose and BSA-methylglyoxal (MGO) systems. The antioxidant capacity was measured by 2,2-diphenyl- -1-picrylhydrazyl (DPPH) and cyclic voltammetry (CV), rutin and D-chiro-inositol contents by HPLC and total phenolics (TPC) by spectrophotometric assays. The study showed the inhibitory effects of extracts from rye-buckwheat ginger cakes supplemented with low and high rutin dosage. The results of the inhibitory activity were highly correlated in two applied model systems. Enrichment of rye-buckwheat ginger cakes with rutin improved their antioxidant properties. The correlation studies showed that the inhibitory effects of rye-buckwheat ginger cakes produced with dough fermentation step and enhanced with rutin against formation of AGEs were highly correlated with TPC, rutin and D-chiro-inositol contents, and antioxidant capacity. Moreover, the effect of rutin enrichment was clearly seen in cakes obtained with dough fermentation step, even the inhibitory activity was slightly lower as compared to the cakes produced without dough fermentation.
1. Alam S., Ahsan A., Alam S., Newer insights in drugs inhibiting formation and accumulation of advanced glycation end products. J. Biochem. Technol., 2013, 5(1), 666-672.
2. Ames J.M., Dietary Maillard reaction products: implications for human health and disease. Czech J. Food Sci., 2009, 27, S66-S69.
3. Annapurna A., Reddy C.S., Akondi R.B., Rao S.R.C., Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozocin- induced type I diabetic rats. J. Pharm. Pharmacol., 2009, 61, 1365-1374.
4. Arendt E., Zannini E., Buckwheat. 2013. In: Cereal Grains for the Food and the Beverages Industry (eds. E. Arendt, E. Zannini). Woodhead Publishing Limited, Cambridge, UK, pp. 369-408.
5. Bhattacherjee A., Chakraborti A.S., Inhibitory effect of Piper betle Linn. leaf extract on protein glycation - quantification and characterization of the antiglycation components. Indian J. Biochem. Biophys., 2013, 50, 529-536.
6. Brand-Williams W., Cuvelier M.E., Berset C., Use of a free radical method to evaluate antioxidant activity. LWT - Food Sci. Technol., 1995, 28, 25-30.
7. Cervantes-Laurean D., Schramm D.D., Jacobson E.L., Halaweish I., Bruckner G.G., Boissonneault G.A., Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J. Nutr. Biochem., 2006, 17, 531-540.
8. Cheang K.I., Baillargeon J.-P., Essah P.A., Ostlund Jr R.E., Apridonize T., Islam L., Nestler, J.E., Insulin-stimulated release of D-chiro-inositol-containing inositophosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metab. Clin. Exp., 2008, 57, 1390-1397.
9. Cosio M.S., Buratti S., Mannino S., Benedetti S., Use of an electrochemical method to evaluate the antioxidant activity of herb extracts from Labiatae family. Food Chem., 2006, 97, 725-731.
10. Esmaeili M.A., Advanced Glycation End Product inhibitory effect of quercetin-3-O-rutinoside, isolated from Teucrium polium. Pharm. Sci., 2014, 19, 125-134.
11. Filipčev B., Šimurina O., Sakač M., Sedej I., Jovanov P., Pestorić M., Bodoža-Solarov M., Feasibility of use of buckwheat flour as an ingredient in ginger nut biscuit formulation. Food Chem., 2011, 125, 164-170.
12. Hao H.H., Shao Z.M., Tang D.Q., Lu Q., Chen X., Yin X.X., Wu J., Chen H., Preventive effects of rutin on the development of experimental diabetic nephropathy in rats. Life Sci., 2012, 91, 959-967.
13. Harris C.S., Beaulieu L.-P., Fraser M.-H., McIntyre K.L., Owen P.L., Martineau L.C., Cuerrier A., Johnson T., Haddad P.S., Bennett S.A., Arnason J.T., Inhibition of advanced glycation end product formation by medical plant extracts correlates with phenolic metabolites and antioxidant activity. Planta Medica, 2011, 77, 289-204.
14. Ho S.C., Wu S.P., Lin S.M., Tang Y.L., Comparison of anti-glycation capacities of several herbal infusions with that of green tea. Food Chem., 2010, 122, 768-774.
15. Hur S.J., Lee S.Y., Kim Y.-C., Choi I., Kim G.-B., Effect of fermentation on the antioxidant activity in plant-based foods. Food Chem., 2014, 160, 346-356.
16. Jiang P., Cambell F.C.B., Pierce G.J., Austria A., Briggs C.J., Rutin and flavonoid contents in three buckwheat species Fagopyrum esculentum, F. tataricum, and F. homotropicum and their protective effects against lipid peroxidation. Food Res. Int., 2007, 40, 356-367.
17. Kamalakkannan N., Prince P.S.M., The influence of rutin on the extracellular matrix in streptozocin-induced diabetic rat kidney.J. Pharm. Pharmacol., 2006, 58, 1091-1098.
18. Kawa J.M, Taylor C.G., Przybylinski R., Buckwheat concentrate reduces serum glucose in streptozotocin diabetic rats. J. Agric. Food Chem., 2003, 51, 7287-7291.
19. Kellow N.J., Savige G.S., Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review. Eur. J. Clin. Nutr., 2013, 67, 239-248.
20. Kiho T., Usui S., Hirano K., Aizawa K., Inakuma T., Tomato paste fraction inhibiting the formation of advanced glycation end-products. Biosci. Biotechnol. Biochem., 2004, 68, 200-205.
21. Larner J., Brautigan D.L., Thorner M.O., D-Chiro-inositol glycans in insulin signaling and insulin resistance. Mol. Med., 2010, 16, 543-551.
22. Markowicz Bastos D.H., Gugliucci A., Contemporary and controversial aspects of the Maillard reaction products. Curr. Opin. Food Sci., 2015, 1, 13-20.
23. Pashikanti S., de Alba D.R., Boissonneault G.A., Cervantes- -Laurean D., Rutin metabolites: Novel inhibitors of nonoxidative advanced glycation end products. Free Radical Biol. Med., 2010, 48, 656-663.
24. Peng X., Ma J., Chen F., Wang M., Naturally occurring inhibitors against the formation of advanced glycation end-products. Food Funct., 2011, 2, 289-301.
25. Przygodzka M., Zielińska D., Ciesarová Z., Kukurová K., Zieliński H., Comparison of methods for evaluation of the antioxidant capacity and phenolic compounds in common spices. LWT - Food Sci. Technol., 2014, 58, 321-326.
26. Ramkissoon J.S., Mahomoodally M.F., Ahmed N., Subratty A.H., Antioxidant and anti-glycation activities correlates with phenolic composition of tropical medicinal herbs. Asian Pac. J. Trop. Med., 2013, 6, 562-569.
27. Scioscia M., Siwetz M., Fascilla F., Huppertz B., Placental expression of D-chiro-inositol phosphoglycans in preeclampsia. Placenta, 2012, 10, 882-884.
28. Singleton V.L., Rossi J.A. Jr., Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Amer. J. Enol. Vitic., 1965, 16, 144-158.
29. Szawara-Nowak D., Koutsidis G., Wiczkowski W., Zieliński H., Evaluation of the in vitro inhibitory effects of buckwheat enhanced wheat bread extracts on the formation of advanced glycation end-products (AGEs). LWT - Food Sci. Technol., 2014, 58, 327-334.
30. Takahama U., Tanaka M., Hirota S., Buckwheat flour and bread. 2011, In: Flour and Breads and their Fortification in Health and Disease Prevention. (eds. V.R. Preedy, R.R. Watson, V.B. Patel). Academic Press , London, UK, pp.141-150.
31. Thornalley P.J., Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation end products. Arch. Biochem. Biophys., 2003, 419, 31-40.
32. Tosun A., Khan S., Antioxidant actions of spices and their phytochemicals on age-related diseases. 2015, In: Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brian Disease, Prevention and Therapy. (eds. R. R. Whatson, V. R. Preddy). Academic Press, London, UK, pp. 311-318.
33. Uribarri J., Cai W., Sandu O., Peppa M., Goldberg T., Vlassara H., Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann. N. Y. Acad. Sci., 2005, 1043, 461-466.
34. Uribarri J., Woodruff S., Goodman S., Cai W., Chen X., Pyzik R., Yong A., Striker G.E., Vlassara H., Advanced glycation end products in foods and practical to their reduction in the diet. J. Am. Diet Assoc., 2010, 110, 911-916.
35. Vlassara H., Uribarri J., Advanced Glycation End Products (AGE) and diabetes: cause, effect, or both? Curr. Diab. Rep., 2014, 14, 453.
36. Yamagishi S., Ueda S., Okuda S., Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders. Curr. Pharm. Des., 2007, 13, 2832-2836.
37. Yang N., Ren G., Determination of D-chiro-inositol in Tartary buckwheat using high-performance liquid chromatography with an evaporative light-scattering detector. J. Agric. Food Chem., 2008, 56, 757-760.
38. Yao Y., Shan F., Bian J., Chen F., Wang M., Ren G., D-chiro-inositol- enriched Tartary buckwheat bran extract lowers the blood glucose level in KK-Ay mice. J. Agric. Food Chem., 2008, 56, 10027-10031.
40. Zielińska D., Szawara-Nowak D., Zieliński H., Determination of the antioxidant activity of rutin and its contribution to the antioxidant capacity of diversified buckwheat origin material by updated analytical strategies. Pol. J. Food Nutr. Sci., 2010, 60, 315-321.
41. Zieliński H., Ciesarova Z., Troszyńska A., Ceglińska A., Zielińska D., Amarowicz R., Przygodzka M., Kukurova K., Antioxidant properties, acrylamide content and sensory quality of ginger cakes with different formulations. Pol. J. Food Nutr. Sci., 2012, 62, 41-50.
42. Zuwało-Jagiełło J., Therapeutic intervention in diseases with advanced glycation end products in their pathogenesis. Pol. Merk.Lek., 2009, 27, 152-158.